Thirty-two (16 male and 16 female) growing cattle were enrolled in a margin of safety study. Calves were injected subcutaneously with either saline, DRAXXIN KP at the label dose 2.5 mg tulathromycin/3 mg ketoprofen/kg BW, DRAXXIN KP at 3 times the label dose, or DRAXXIN KP at 5 times the label dose.
IMPORTANT SAFETY INFORMATION FOR DRAXXIN KP: Draxxin KP has a pre-slaughter withdrawal time of 18 days in cattle. Not for use in female dairy cattle 1 year of
Cattle were given a single subcutaneous dose of one of the following: (1) Draxxin KP; (2) Draxxin (which contains tulathromycin alone and is
Calves were injected subcutaneously with either saline, DRAXXIN KP at the label dose 2.5 mg tulathromycin/3 mg ketoprofen/kg BW, DRAXXIN KP at. 3 times the
Calves were injected subcutaneously with either saline, DRAXXIN KP at the label dose 2.5 mg tulathromycin/3 mg ketoprofen/kg BW, DRAXXIN KP at 3 times the label dose, or DRAXXIN KP at 5 times the label dose. Calves received three doses at a14-day interval between doses.
success rates to calves receiving Draxxin alone.3-4 Help get your cattle Draxxin KP animals showed a numerically improved attitude compared with saline-alone and Draxxin-treated animals.2 IMPORTANT SAFETY INFORMATION: Draxxin KP has a pre-slaughter withdrawal time of 18 days in cattle. Not for use in female
DRAXXIN KP (tulathromycin and ketoprofen) Injectable Solution, Cattle PART 522IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS.
Cattle were given a single subcutaneous dose of one of the following: (1) Draxxin KP; (2) Draxxin (which contains tulathromycin alone and is
The dosage of Draxxin KP for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida
Your stories have no coherence.